Skip to main content
Equibles

Larson Financial Group LLC

Position in FLNA — Filana Therapeutics, Inc.

CIK 1731061 ST LOUIS, MO
Back to FLNA Full portfolio

Position in FLNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11
-$5 QoQ
Shares Held
10
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 84 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Derivatives in FLNA

reported options exposure · as of Mar 31, 2023
CallValue
$107
CallShares
200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Larson Financial Group LLC holds $5,718,078 across 194 Biotechnology names. FLNA ranks #186 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,302 $646,742
2 INCY
Incyte Corp
 4,050 $459,108
3 TGTX
Tg Therapeutics, Inc.
 7,292 $400,622
4 REGN
Regeneron Pharmaceuticals, Inc.
 627 $390,959
5 EXEL
Exelixis, Inc.
 4,507 $245,225
6 IONS
Ionis Pharmaceuticals Inc
 3,000 $237,870
7 ALNY
Alnylam Pharmaceuticals, Inc.
 613 $184,531
8 JAZZ
Jazz Pharmaceuticals plc
 709 $170,847

All Filings in FLNA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11 10
2026-03-31 $16 10
2025-12-31 $19 10
2024-09-30 $2,943 100
2024-06-30 $1,235 100
2024-03-31 $2,029 100
2023-12-31 $2,251 100
2023-09-30 $1,664 100
2023-06-30 $2,452 100
2023-03-31 $2,412 100
2023-03-31 $107 200
2022-12-31 $1,152 39
2022-09-30 $1,630 39
2021-09-30 $2,607 42